Andera Partners 4
4 · Axonics Modulation Technologies, Inc. · Filed Jan 22, 2020
Insider Transaction Report
Form 4
Andera Partners
10% Owner
Transactions
- Sale
Common Stock
2020-01-17$31.51/sh−164,739$5,191,486→ 3,092,722 total(indirect: See footnote) - Sale
Common Stock
2020-01-22$31.54/sh−135,261$4,266,389→ 2,957,461 total(indirect: See footnote)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $31.50 to $31.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]2,224,128 shares are held of record by BioDiscovery 4 FCPR ("BioDiscovery") and 733,333 shares are held of record by BioDiscovery 5 ("BioDiscovery 5"). Andera Partners ("Andera") is the manager of BioDiscovery and BioDiscovery 5 and may be deemed to have sole voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5.
- [F3]This transaction was executed in multiple trades at prices ranging from $31.50 to $32.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.